FDA Adverse Event Injury Summary report: N

ISTENT TRABECULAR MICRO-BYPASS

MDR report key: 8546951 · Received April 24, 2019

Report

Report Number
2032546-2019-00053
Event Type
Injury
Date Received
April 24, 2019
Report Date
April 24, 2019
Manufacturer
GLAUKOS CORPORATION
Product Code
OGO
PMA / PMN Number
P080030
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SD, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AGE OR DATE OF BIRTH: (MEAN AGE USED), SEX: (MODE USED). THE DEVICES WERE NOT AVAILABLE FOR RETURNED; THEREFORE, PRODUCT TESTING ON THESE ACTUAL DEVICES COULD NOT BE PERFORMED. DEVICE IDENTIFIERS WERE NOT PROVIDED; THEREFORE, THE DEVICE HISTORY RECORDS FOR THIS DEVICE LOT NUMBER COULD NOT BE REVIEWED. ELEVATED IOP IS IDENTIFIED IN THE LABELING AS A KNOWN INHERENT RISK OF TRABECULAR MICRO-BYPASS STENT PROCEDURE. THE IFU ADEQUATELY PROVIDES INSTRUCTIONS FOR STENT IMPLANTATION, PRECAUTIONS, AND WARNINGS FOR THE PROPER USE AND HANDLING OF THE DEVICE. MFR# REFERENCE: (B)(4). THIS STUDY WAS A CONTINUATION AND EXPANSION OF A PREVIOUS STUDY, REFERENCE MFR# (B)(4).

Description of Event or Problem · 1

THROUGH A REVIEW OF THE ARTICLE "TRABECULAR MICRO BYPASS STENT IMPLANTATION IN PSEUDOPHAKIC EYES WITH OPEN-ANGLE GLAUCOMA: LONG-TERM RESULTS¿, THE FOLLOWING WAS REPORTED. NO CASES OF HYPOTONY OCCURRED POSTOPERATIVELY. THERE WERE NO INTRAOPERATIVE OR POSTOPERATIVE COMPLICATIONS OBSERVED RELATED TO THE STENT. FOR PRESSURE SPIKES ABOVE BASELINE, ONLY 3 (5.7%) OF THE 51 EYES EXPERIENCED AN IOP SPIKE OF 15 MM HG OR HIGHER AND 8 EYES (15.3%) HAD IOP SPIKES OF 10 MM HG OR HIGHER, ALL OCCURRING WITHIN 1 MONTH AFTER SURGERY. THIS WAS RETROSPECTIVE ANALYSIS OF DATA COLLECTED FROM 51 EYES OF 40 PATIENTS. PATIENTS WITH MILD TO SEVERE OPEN ANGLE GLAUCOMA WERE IMPLANTED WITH 1 TRABECULAR MICRO BYPASS STENT. PURPOSE: TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF A TRABECULAR MICRO BYPASS STENT AS A SOLE PROCEDURE IN PSEUDOPHAKIC EYES WITH OPEN-ANGLE GLAUCOMA. CONCLUSION: THE INSERTION OF A SINGLE TRABECULAR MICRO BYPASS STENT EFFECTIVELY PROVIDED A SUSTAINED REDUCTION IN IOP PSEUDOPHAKIC PATIENTS WITH MILD TO SEVERE OAG. THE IOP REDUCTION WAS MORE ROBUST IN EYES THAT HAD A HIGHER BASELINE IOP. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
338807 ISTENT TRABECULAR MICRO-BYPASS INTRAOCULAR PRESSURE LOWERING IMPLANT OGO GLAUKOS CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 83 YR Other